On the contrary, the melatonin administration normalised superoxide dismutase activity and iNOS levels under hyperglycaemia to be comparable to those under normoglycemia, suggesting its antioxidant properties for the human dental pulp cells in patients with type 2 diabetes mellitus. The gene discussed is NOS2; the disease is type 2 diabetes mellitus.